Stephanie Tilenius - 18 Feb 2026 Form 4 Insider Report for Zoetis Inc. (ZTS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Feb 2026, 20:54:00 UTC
Prior SEC filing
02 Dec 2025
Next SEC filing
06 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brenda Santuccio, as Attorney-in-Fact

Key filing fact

Stephanie Tilenius filed Form 4 for Zoetis Inc. (ZTS) on 19 Feb 2026.

Key facts

  • This page summarizes Stephanie Tilenius's Form 4 filing for Zoetis Inc. (ZTS).
  • 1 reported transaction and 2 derivative rows are listed below.
  • Accepted by SEC: 19 Feb 2026, 20:54.

Change

  • Previous filing in this sequence was filed on 02 Dec 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001534995 Primary reporting owner

Tilenius Stephanie

Relationship
Director
Address
C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY
Signature
/s/ Brenda Santuccio, as Attorney-in-Fact
Signature date
19 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZTS transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+1,936
Change %
Price
$0.000000
Shares after
1,936
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,936
Exercise price
Footnotes
F1, F2, F3, F4
ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,972
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,972
Exercise price
Footnotes
F1, F2, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

Footnote F3

Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F4

Not applicable.

Footnote F5

Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, December 1, 2025, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .